CC-90001

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	3

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-003473-17-GB (EUCTR)	14/09/2017	24/02/2017	Investigation to Efficacy and Safety of CC-90001 in patients with Idiopathic Pulmonary Fibrosis	A Phase 2, 24-Week Randomized, Double-blind, Placebo-ControlledMulticenter Study, With an 80-Week Ac ...	IDIOPATHIC PULMONARY FIBROSIS MedDRA version: 20.0;Level: LLT;Classification code 10067761;Term: Exa ...	Product Code: CC-90001 INN or Proposed INN: Not available	Celgene Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	210	Phase 2	Colombia;Russian Federation;Romania;United States;United Kingdom;Greece;Canada;Turkey;Taiwan;Brazil; ...
2	NCT03142191 (ClinicalTrials.gov)	July 26, 2017	24/4/2017	A Study to Evaluate the Efficacy and Safety of CC-90001in Subjects With Idiopathic Pulmonary Fibrosi ...	A Phase 2, 24-Week, Randomized, Double-blind, Placebo-controlled, Multicenter Study, With an 80-Week ...	Idiopathic Pulmonary Fibrosis;Fibrosis;Idiopathic Interstitial Pneumonias;Pathologic Processes;Lung ...	Drug: CC-90001;Other: Placebo	Celgene	NULL	Completed	40 Years	N/A	All	138	Phase 2	United States;Australia;Brazil;Canada;Colombia;Germany;Greece;Romania;Russian Federation;Taiwan;Turk ...
3	EUCTR2016-003473-17-GR (EUCTR)	05/05/2017	02/03/2017	Investigation to Efficacy and Safety of CC-90001 in patients with Idiopathic Pulmonary Fibrosis	A Phase 2, 24-Week Randomized, Double-blind, Placebo-Controlled Multicenter Study, With an 80-Week A ...	IDIOPATHIC PULMONARY FIBROSIS MedDRA version: 20.0;Level: LLT;Classification code 10067761;Term: Exa ...	Product Code: CC-90001	Celgene Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	135	Phase 2	United States;Taiwan;Greece;Turkey;Russian Federation;Colombia;United Kingdom;France;Canada;Brazil;R ...

First Previous1Next Last